Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Lupin secures US FDA tentative approval for generic version of Slynd contraceptive tablets Lupin wins US FDA tentative approval for generic drospirenone contraceptive, targeting a $141M US market. See how this move fits its women’s health strategy. byPallavi MadhirajuNovember 4, 2022